Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week‐112 Efficacy and Safety Results of the Open‐Label Long‐Term Extension of a Phase III, Double‐Blind, Randomized, Placebo‐Controlled Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|67|12|1627-1636

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.67, Iss.12, 2015-12, pp. : 1627-1636

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1739-1749

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III, double‐blind, randomized, placebo‐controlled trial

By  

EPILEPSIA, Vol. 56, Iss. 2, 2015-02 ,pp. : 244-253

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial – an Indian experience

By Kumar Das Siddharth   Pareek Anil   Mathur D. S.   Wanchu Ajay   Srivastava Ragini   Agarwal G. G.   Chauhan R. S.  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2227-2234

Informa Healthcare

Access to resources Recommend Favorite

Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 12, 2014-12 ,pp. : 3255-3264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Efficacy of Atacicept in Combination With Rituximab for Reducing the Signs and Symptoms of Rheumatoid Arthritis: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Pilot Trial

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 11, 2015-11 ,pp. : 2828-2836

John Wiley & Sons Inc

Access to resources Recommend Favorite